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ABST RACT
Necrotizing fasciitis is a rapidly destructive affliction of soft tissues, with a
mortality rate that may reach 73% of the cases. It is characterized by a
progressive inflammation and extended necrosis of the subcutaneous tissue and
the fascia. Necrotizing fasciitis was first described in 1848, and later in 1920
Meleney identified 20 patients in China in which the infection was presumably
triggered by hemolytic streptococcus, linking pathological bacteria to the
condition. In 1952, Wilson coined the term necrotizing fasciitis although without
successfully identifying the specific pathological bacteria involved. In most
cases, both risk and aggravating factors are present, the main risk factors being
diabetes mellitus, liver cirrhosis, renal failure, and immunosuppressant states.
Location may vary, but most frequently the disease occurs in the limbs, the
trunk, and the perineum. Treatment depends on the location and the time of
diagnosis and may range from large incisions with extensive debridement to
organ amputations such as those of the limbs or breasts. Treatment is complex
and expensive, and besides surgery, includes the administration of broad spectrum antibiotics, anti-inflammatory drugs, intensive therapy support, and
long-term hospitalizations. The prognosis is guarded. The present case entails a
56-year old female patient who presented with many risk factors favoring the
occurrence of necrotizing fasciitis, namely diabetes mellitus, liver cirrhosis
(decompensated with ascites and portal encephalopathy phenomena), untreated
hepatitis B infection, chronic renal failure with diabetic nephrotic syndrome, and
obesity.

Introduction
Necrotizing fasciitis has been defined as a severe
infection of soft tissues which includes extended necrosis
of the fascia and the subcutaneous tissue, with the relative
sparing of the muscles and skin [1]. As the disease
progresses, the thrombosis of cutaneous perforants will
cause the devascularization of the skin, leading to its
necrosis. Sepsis will invariabley develop, depending on the
bacteriological cultures. There are 3 types of necrotizing
fasciitis: type I consists of polymicrobial infections, type II
consists of group A streptococcal infections alone or
associated with Staphylococcal infections, and type III
consists of Vibrio species infections. However, recent
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studies have revealed that the microbial flora is constantly
undergoing change and is becoming increasingly resistant
to antibiotics, for example, with reported cases in which the
Staphylococcus aureus has been resistant, including to
Methicillin [2]. Moreover, given that necrotizing fasciitis
most often occurs on biological soil, bacteria with
increased aggressiveness may also be involved, for
example Klebsiella pneumonia [3]. Despite aggressive
treatment, the mortality rate remains high, ranging between
52 and 72% [4,5]. In most cases, necrotizing fasciitis
occurs when there is decreased immunity, being associated
with diseases such as myelodysplastic syndrome, liver
cirrhosis, diabetes mellitus, cancer, and chronic obstructive
arteriopathy [6-8].
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Case Report

Discussions

A 56-year-old female patient presented to the surgical
unit with painful right inguinal adenopathy. Clinically, the
presence of a right inguinal adenopathy of about 4/2/2/ cm
was noticed. It was mobile, well outlined, painful
spontaneously and also upon palpation. The patient
presented with associated decompensated type II diabetes
mellitus,
liver
cirrhosis
decompensated
both
parenchymatously and vascularly, with ascites occurring
due to a HBV infection, alcohol consumption, and obesity.
Preoperative tests also revealed moderate anemia (Hb=9.8
mg/dl) and chronic renal failure, probably due to diabetic
nephropathy (creatinine 1.4), while the inter-clinical
consultation on internal medicine also revealed stage II
AHT.
Despite the associated pathology, and after the
preliminary postponement of the surgical intervention, the
patient insisted on the surgical removal of the inguinal
ganglion, on the one hand, because of the local pain, and
on the other hand because of the suspicion of the family
doctor of a possible lymphoma at onset.
The ablation of the inguinal ganglion was performed
under local anesthesia, through a minimally invasive
approach, a horizontal incision at approximately 4-5 cm
under the inguinal arch, about 5-6 cm long. The immediate
postoperative evolution was favorable, without any
complications.
On admission, the patient had been on a course of selfadministerd Augmentin for 3 days. Two days after the
intervention, the patient requested the discharge, and 6
hours later she returned, indicating pain at the incision site.
Locally, the patient presented slight edema and erythema
along with mild pain. She was re-operated on and the local
necrosis of the fascia was noticed. It was debrided and
broad-spectrum antibiotic therapy was initiated (Meronem
with Vancomycin), as well as volemic support. The
cultures showed the presence of enterococcus. Despite the
established medication, the necrotizing fasciitis
extended, the incisions were enlarged, with massive
debridement, but the blood glucose level could not be
established.
Given the low immunity determined by
decompensated liver cirrhosis, the HBV infection, and
decompensated diabetes mellitus, the general condition
of the patient progressively worsened, with the decrease
in plasma levels of hemoglobin and albumin, with
hydro-electrolytic imbalances, metabolic acidosis etc.,
which could not be compensated despite all the efforts.
The patient died 3 weeks after the onset of the
necrotizing fasciitis.

Early diagnosis of necrotizing fasciitis is difficult
because the first manifestations consist of edema,
erythema, and possible mild paresthesia. Laboratory test
results are unchanged from those in the first stage of the
disease [9]; as a result, the condition is often diagnosed late
when the first complications have already occurred. Since
there are no specific signs or symptoms for diagnosis, we
considered that the first step in the diagnosis of necrotizing
fasciitis is its suspicion at the smallest signs of local
inflammation, in immunosuppressed patients and with
favoring factors.
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Once suspected or diagnosed, the protocol treatment for
necrotizing fasciitis includes:
1. Assessment of the biological field, co-morbidities, and
aggravating and prognostic factors;
2. Large and extensive incisions, with the debridement of
all necrotizing tissues;
3. Broad-spectrum antibiotic therapy;
4. Intensive therapy with inotropic support medication
which supports blood pressure at values higher than 65
mm Hg;
5. Reconstructive surgery.
The assessment of the biological field is done first
through a thorough case history and the study of the
patient’s medical history in order to identify associated
diseases, and second, through detailed laboratory tests: a
complete blood count, ionogram, C-reactive protein, blood
glucose levels, stress hyperglycemia ratio (IQR), HbA1c,
glycemic variation (the difference between the level of
hyperglycemia and that of hypoglycemia), urea, sodium,
albumin, creatinine, liver transaminases, GGT, ALP,
bilirubin. Additionally, glycosylated hemoglobin, AgHBs,
HCV, HIV, uric acid, etc. can also be ordered [8-10].
The value of blood glucose levels and glycemic
variations is currently a debated topic. Many critical
illnesses cause stress-induced hyperglycemia by producing
excessive catecholamine, glycogen, and inflammatory
cytokines, thus leading to the increase of glucogenesis and
insulin resistance [11]. Yet hyperglycemia may also be a
distinctive sign of severity in patients with associated
diseases [12]. Egi et al. have demonstrated that acute
hyperglycemia can affect mortality in diabetic patients
with other critical illnesses [13]. However, glycated
hemoglobin (HbA1c) is not influenced by acute stress or
sepsis [14].
Po-Chuan Chen et al. conducted a study on 252
patients, which focused on the role of glycemic variation
as a predictive factor for necrotizing fasciitis. This study
revealed that a glycemic variation ≥ 146 mg/dl with or
without hyperglycemia on admission and with an
APACHE II score ≥ 15, had favored the development of
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complications in patients with necrotizing fasciitis,
especially bacteremia and acute renal failure. Thus, it was
used as a predictive factor in the occurrence of
complications and the evaluation of the prognosis in
patients with necrotizing fasciitis [8].
The American Society of Anesthesia (ASA) has
developed a system of evaluation for the systemic
inflammatory response syndrome (SIRS) that we find
useful (Table 1).
In the case of monomicrobial infections, the most
frequently implicated germs are group A streptococcus,
group B streptococcus, staphylococcus aureus, aeromonas
hydrophilia, vibrio vulnificus, Escherichia colli, klebsiella
pneumoniae, and pseudomonas aeruginosa, while in the
case of plurimicrobial infections, there may be various

combinations of these germs [15]. Approximately 60-80%
of the infections related to necrotizing fasciitis are
monomicrobial [16, 17]. Finegoldia magna may also be
implicated when determining microbial infections in the
case of necrotizing fasciitis in the diabetic patient [18].
Finegoldia magna is a Gram-positive anaerobic coccus of
the Clostridiales family, which together with other Grampositive anaerobic cocci (GPAC), had been known until
1999 to be part of Peptostreptococcus magnus, being a
pathogenic germ that normally colonizes the skin and the
mucous membranes, but which can cause severe infections
in case of low immunity, as in the case of a diabetic patient
[19,20]. The Klebsiela Pneumoniae infections are
associated with an increased risk of death [15] (Table 1).

Table 1. The evaluation system of the Systemic Inflammatory Response Syndrome (SIRS) [15].

Variable

Definition

Diabetes mellitus

The diagnosis is based on one of the four abnormalities identified by the American Diabetes
Association, 2010: glycated hemoglobin (A1C) ≥6.5%, fasting plasma glucose (FPG) ≥126
mg/dl, random plasma glucose ≥200 mg/dl with symptoms, or two-hour plasma glucose
≥200 mg/dl during an oral glucose tolerance test (OGTT)

Functional Status

Patient requiring no, partially, or totally dependent assistance from another person for
regular daily activities before surgery

Hypertension

Patient with elevated blood pressure requiring medication

Chronic renal failure

Patient with increasing creatinine levels >3 mg/dl or a decreased glomerular filtration rate
of less than 60 ml/min/1.73 m2 for 3 or more months

Liver cirrhosis

Diagnosis based on clinical, laboratory, and echographic findings

SIRS

Includes the presence of two or more of the following: temperature >38 °C or <36 °C, heart
rate >90 bpm, respiratory rate >20 breaths/min or PaCO2 < 32 mm/Hg, WBC >12,000/mm3
or <4,000/mm3, or >10 % immature (band) forms, anion gap acidosis

Septic shock

Includes sepsis and documented organ and/or circulatory dysfunction

Limb loss

Amputation of the lower or upper limb above the ankle or the wrist, respectively.

ASA score

1 = normal healthy patient
2 = patient with mild systemic disease
3 = patient with severe systemic disease
4 = patient with severe systemic disease that is a constant threat to life
5 = moribund patient who is not expected to survive without the operation
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The most frequent location of necrotizing fasciitis is
by far the lower limb, followed by the upper limb, the
trunk, and the neck, in order of the incidence [15, 21-24].
The development of peripheral diabetic micro- and
macroangiopathy in the lower limb of the diabetic patient
is the main factor that favors the location of necrotizing

hemodynamic rebalancing, surgical treatment of
cleanliness, and reconstruction. The antibiotic treatment
is generally done with broad-spectrum antibiotics from
the penicillin and cephalosporin classes, and, of course, is
dictated by the microbial flora involved and its resistance
and sensitivity to antibiotics [33]. In cases of microbial

fasciitis, especially in the lower limb of the diabetic patient.
The treatment of choice for necrotizing fasciitis in the
pelvic limb consists of large incisions and necrectomy, the
amputation of the thigh being the last resort in saving the
patient’s life [25]. The development of necrotizing fasciitis
in the genital and perineal regions is known as Fournier’s
gangrene, with an incidence of 0.4-1/100,000, with a slight
increase in incidence in recent years. As in most cases of

flora resistant to the usual antibiotics, Vancomycin is
most often administered. The knowledge of the microbial
flora generally involved in the occurrence of necrotizing
fasciitis and its sensitivity can usually help establish an
efficient antibiotic treatment from the outset and thus
save the patient’s life.
Surgical treatment can vary from the simple
debridement to the disarticulation of the limb from the

necrotizing fasciitis, the inoculation gate of germs is small
[26]. However, it may also occur in less common

coxo-femoral joint [34]. Based on recent studies regarding
predictive factors for pelvic limb amputation, the

anatomical regions, such as the breast, in which case the
mortality is 72% (5), the youngest patient reported with
such a location of the disease was only 23 years old, non-

occurrence of necrotizing fasciitis in this limb in diabetic
patients has an amputation rate that reaches 95%,
compared with an amputation rate of 14.2% in all diseases

diabetic, and the only pathogenic association being obesity
[27].

for diabetic patients, having by far the highest amputation
rate of the lower limb [35]. Compared to non-diabetic

Most cases of necrotizing fasciitis of the breast have
been reported during lactation, with only 6 cases currently
reported unrelated to lactation [27]. In the case of
necrotizing fasciitis of the breast, mortality can be reduced
by up to 10% if an early diagnosis is made and the rapid
establishment of the surgical treatment is possible, through
massive debridement, antibiotic therapy, and antiinflammatory treatment, along with support of volemic and

patients, the plurimicrobial infection rate and the
amputation rate due to necrotizing fasciitis is significantly
higher in patients with necrotizing fasciitis and diabetes
[36].
As a therapeutic alternative, negative pressure vacuum
can be used. It may also be used as a first therapeutic
alternative in the necrosis of the breast [27, 37]. Neumaier
suggests that negative pressure wound therapy (NPWT)

hydro-electrolytic balance [28]. The cervical location of
necrotizing fasciitis is also extremely rare, but not
excluded, such cases being reported, sometimes even with

may be superior to negative pressure systems, especially
for aggressive infectious wounds which release many
endotoxins and necrotic defects, as the negative pressure

and odontogenic starting point, the main determinism
being pulp necrosis with the bacterial invasion of the
periapical tissue, leading to the formation of purulent

system facilitates removal of interstitial fluids [38]. NPWT
systems work by introducing positive pressure in the
wound bed. This creates an area of local hypoxic tissue

collections [29]. The periorbital area where the fascia is

which is surrounded by an area of hyperemia in the

poorly represented is also not excluded from such
pathology, cases of periorbital necrotizing fasciitis having
reported local trauma, either accidental or iatrogenic
(surgical), the prognosis being better in such cases.
However, there is the possibility of complications such as
optic neuropathy, retinal vein occlusion, keratopathy,
cavernous sinus thrombosis, meningitis, vision loss and
death [30-32].

perilesional tissue [39]. Moreover, following the
application of NPWT, debridement is accelerated in a
manner similar to autolyzed debridement, and physical
debridement is favored by the granulation tissue growth as
well as by the local growth factors, thus facilitating healing
[40]. Gabriel et al. reported that NPWT combined with
topical irrigation after debridement is superior to standard
NPWT treatment for infection control; this combination

The treatment for necrotizing fasciitis is complex and
multimodal, consisting of broad-spectrum antibiotic
therapy, anti-inflammatory drugs, hemodynamic support,

treatment may decrease the healing time, the length of the
hospital stays, and the duration of the therapy [41]. Along
similar lines, Matiasek et al. reported a case study that
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combined NPWT with application of octenidine in the
wound, arguing that it would facilitate more rapid healing
of the wound [42].
The most concerning complications of necrotizing
fasciitis are: (1) acute renal lesions (defined as increases
in serum creatinine level > 0.5 mg / dL compared to prior

For evaluation of the severity of necrotizing fasciitis,
as well as for the prognosis, we consider prediction scores
to be helpful. The most widely used is the LRINEC
(Laboratory Risk Indicator for Necrotizing Fasciitis)
score (Table 1). This score classifies patients into three
groups:

to or upon admission); (2) acute respiratory failure that
requires orotracheal intubation and mechanic ventilation
support; (3) bacteremia (defined as positive blood
culture); (4) septic shock (defined by the clinical criteria
of sepsis and the need for vasopressor therapy necessary
to maintain an average blood pressure of 65 mm Hg and
lactate > 2 mmol / L in the absence of hypovolemia); and
(5) death. Wound healing may also be influenced by the

• low risk (LRINEC score ≤ 5 points, <50% risk of
necrotizing fasciitis);

type of the bacteria involved, and systemic antibiotic
therapy may involve disturbances of the adjacent
cutaneous microbioma or distal ones in the presence of
comorbidities [15,43-51].

Reactive C Protein

Leukocyte

Hemoglobin

Serum Sodium

Creatinine

Glucose

• high risk (LRINEC score ≥ 8 points,> 75% risk of
necrotizing fasciitis).
Studies on the LRINEC score have shown that a score
≥ 6 as a reduction of necrotizing fasciitis gave a positive
predictive value (PPV) of 92% and a negative predictive
value (NPV) of 96%. Approximately 90% of patients with
necrotizing fasciitis had LRINEC scores ≥6 points, while
only 3.1% up to 8.4% of the control-group patients had
LRINEC scores ≥ 6 points. 10% of the patients with
necrotizing fasciitis had a LRINEC score < 6 [52, 53]
(Table 2).

Table 2. LRINEC Score [52].
Biologic
Parameter

• moderate risk (LRINEC score 6-7 points, 50%-75%
risk of necrotizing fasciitis);

Score

Wagner’s score can also be useful as predictive factors
in evaluating lesions of the diabetic foot [54-56].

Under 15 mg/dl

0

Over 15 mg/dl

4

Under 15,000 /µl

0

For the evaluation of the general state of the patient, of
the severity of the disease and the general prognosis, the
APACHE II score can provide good results [57] (Table 3
and 4).

15,000-25,000 /µl

1

Over 25,000 /µl

2

Over 13.5 mg/dl

0

Degree

11-13.5 mg/dl

1

0

Intact Skin

Under 11 mg/dl

2

I

Over 135 mEq/l

0

Superficial ulcer of skin or subcutaneous
tissue

Under 135 mEq/l

2

II

Ulcers extend into the tendon, bone or
capsule

Under 1.6 mg/dl

0
III

Deep ulcer with osteomyelitis or abscess

Over 1.6 mg/dl

2

Under 180 mg/dl

0

IV

Partial foot gangrene

Over 180 mg/dl

1

V

Whole foot gangrene

Value

Table 3. Wagner’s Classification for diabetic ulcer
patients [53].
The description of the injury
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Table 4. Apache II Score [54].
Physiologic
variable

Point score
+4

+3

+2

+1

0

+1

+2

+3

+4

Temperature
Mean
arterial
pressure
(mmHg)
3
Heart rate
Respiratory
4
rate
5
Oxygenation
a) FiO2≥0.5
b) FiO2≤0.5
6
Arterial pH
Serum Na
7
(mMol/L)
Serum K
8
(mMol/L)
Serum
9
creatinine
(mg/dl)
10 Hct (%)
11 WBC (in
1000)
12 Glasgow
coma score

≥41
≥160

39-40
130-159

110-129

38.5-38.9
-

36-38.4
70-109

34-35
-

32-33
50-69

30-31
-

≤29.9
≤49

≥180
≥50

140-179
35-49

110-139
-

25-34

70-109
12-24

10-11

55-69
6-9

40-54
-

≤39
≤5

≥500
≥7.7
≥180

350-499
7.6-7.69
160-179

200-349
155-159

7.5-7.59
150-154

<200
>70
7.33-7.49
130-149

61-70
-

≥7

6-6.9

-

5.5-5.9

3.5-5.4

3-3.4

2.5-2.9

-

≤2.5

≥3.5

2-3.4

1.5-1.9

-

0.6-1.4

-

<0.5

-

--

≥60
≥40

-

50-59.9
20-39.9

46-49.9
15-19.9

30-45.9
3-14.9

-

20-29.9
1-2.9

-

<20
<1

13d

≥52

1
2

55-60
<55
7.25-7.32 7.15-7.24 <7.15
120-129 111-119 ≤110

Score
-15
minus
actual
GCS
The acute physiology score is the sum of the 12 individual variable points.
Add 0 points for the age < 44; 2 points for 45-54 years; 3 points for 55-64; five points for 65-74 years and six points
≥75 years.
APACHE II Score – acute physiology score + age points + Chronic health points. The maximum score is 71.
Increasing score is associated with increasing risk of hospital death.
Add chronic health status points: two points in elective postoperative patient with immuno-compromised state or a
history of severe organ failure: five points for non-operative patient or emergency postoperative patient with
immuno-compromised state or severe organ failure.
Serum
HCO3
(venous –
mMol/l)

41-51.9

-

32-40.9

22-31.9

-

18-21.9

15-17.9

<15

Interpretation of APACHE II Scores:
0-4: ~4% death rate; 5-9: ~8% death rate; 10-14: ~15% death rate; 15-19: ~25% death rate; 20-24: ~40% death rate;
25-29: ~55% death rate; 30-34: ~75% death rate; over 34: ~85% death rate
a
APACHE II Score – acute physiology score + age points + Chronic health points. The maximum score is 71.
Increasing score is associated with increasing risk of hospital death
b
choose the worst value in the past 24 h
c
chronic health status: organ failure or an immuno-compromised state must have preceded current admission
d
optional variable
124
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Highlights
✓ Necrotizing fasciitis is a severe infection of soft tissue
with extended necrosis of the fascia and subcutaneous
tissue and may involve muscles and skin.
✓ Necrotizing fasciitis is common in patients with
diabetes mellitus, with high mortality for these
patients.

Conclusions
Although diabetes mellitus is a risk factor for the
occurrence of necrotizing fasciitis, no major differences in
mortality between those with and without diabetes mellitus
occurs. Thus, we can conclude that although necrotizing
fasciitis is favored by diabetes mellitus, once installed, its
mortality is equally high irrespective of the patient’s
diabetes status. However, if it is also associated with other
co-morbidities besides diabetes mellitus, such as liver
cirrhosis or immune-depression, the risk of death increases
greatly. The diagnosis is extremely difficult, as there are
practically no specific signs or symptoms or conclusive
laboratory investigations. The tentative diagnosis is the
suspicion of fasciitis in a patient with low immunity, which
is confirmed after incisions reveal fasciitis. Treatment is
complex, with broad-spectrum antibiotic therapy, volemic
and hydroelectrolytic support, the treatment of associated
diseases. Surgical treatment consists of large incisions and
extended fasciectomies, followed by plastic reconstruction.
Still, the prognosis is poor, with a mortality rate that can
even reach up to 73%.
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